Researcher
Johannes Heemskerk
- Keywords:Medicine
Affiliations
- Supporting clinical sciences (Department)
Member
From1 Jan 2014 → 14 Feb 2018 - Medical Imaging (Research group)
Member
From1 Feb 2012 → 1 Dec 2019 - Medical Imaging and Physical Sciences (Department)
Member
From1 Feb 2012 → 31 Dec 2013 - Nuclear Medicine (Department)
Member
From9 Feb 2011 → 1 Dec 2019
Publications
1 - 10 of 18
- Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)(2023)
Authors: Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, Christel Fontaine, et al.
Pages: 1378-1384 - Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - Gamma detector dead time correction using Lambert W function(2020)
Authors: Johannes Heemskerk, Michel Defrise
- Population Pharmacokinetic Approach Applied to Positron Emission Tomography(2017)
Authors: Peggy Gandia, Cyril Jaudet, Hendrik Everaert, Johannes Heemskerk, A Vanbinst, Johan De Mey, Johnny Duerinck, Bart Neyns, Mark De Ridder, Etienne Chatelut, et al.
Pages: 953-961 - (18)F-nanobody for PET imaging of HER2 overexpressing tumors(2016)
Authors: Catarina Xavier, Anneleen Blykers, Ilse Vaneycken, Matthias D'Huyvetter, Johannes Heemskerk, Tony Lahoutte, Nick Devoogdt, Vicky Caveliers
Pages: 247-52 - Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma(2016)
Authors: Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Chloé Ackaert, Marian Vanhoeij, Francois P Duhoux, Thierry Gevaert, Pascal Simon, et al.
Pages: 27-33 - PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments(2015)
Authors: Anneleen Blykers, Steve Joël Marie-José Schoonooghe, Catarina Xavier, Kevin D'Hoe, Damya Laoui, Matthias D'Huyvetter, Ilse Vaneycken, Frederik Cleeren, Guy Bormans, Johannes Heemskerk, et al.
Pages: 1265-1271 - Radiolabeled mannosylated dextran derivatives bearing an NIR-fluorophore for sentinel lymph node imaging(2014)
Authors: Mauricio Morais, Maria P C Campello, Catarina Xavier, Johannes Heemskerk, João D G Correia, Tony Lahoutte, Vicky Caveliers, Sophie Hernot, Isabel Santos
Pages: 1963-1970 - Synthesis, preclinical validation, dosimetry and toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer(2013)
Authors: Catarina Xavier, Ilse Vaneycken, Johannes Heemskerk
Pages: 776-784 - Improved EMCCD gamma camera performance by SiPM prelocalization(2012)
Authors: Samuel Salvador, Marc A N Korevaar, Johannes Heemskerk, Rob Kreuger, J. Huizenga, S Seifert, D. Schaart, Freek Beekman
Pages: 7709-7724